This Week at FDA: FY2025 budget roadblock, Biosimilar PSGs, and more

This Week at FDAThis Week at FDADiagnostics/IVDsGovernment/legislationGuidanceMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)